DrFirst acquires Myndshft to expedite access to specialty medications and reduce burden on providers

DrFirst has recently announced its strategic acquisition of Myndshft Technologies, Inc., a pioneer in end-to-end real-time medical benefits and automated prior authorization (PA) software-as-a-service (SaaS).

Myndshft's software-as-a-service is designed to streamline and automate labour-intensive healthcare tasks such as prior authorization, eligibility and benefits verification, and managing patient financial responsibilities. By partnering with leading providers, payers, and health information exchanges, Myndshft has positioned itself as an essential player in modernising healthcare operations.

The acquisition focuses primarily on enhancing the prior authorization (PA) process for specialty medications, including infusions and injectables, which are often vital for patient well-being but are subject to complex and time-consuming approval procedures.

Myndshft's technology stands out as an automation powerhouse, leveraging cutting-edge AI, machine learning, and robotic process automation (RPA) to automate tasks across different payers and treatment categories. Its unified platform seamlessly integrates with existing systems, eliminating the need for multiple platforms and manual data entry. Moreover, Myndshft takes a holistic approach by streamlining processes for labs and imaging procedures often required before obtaining specialty medications.

The acquisition promises substantial benefits for patients, providers, and the healthcare system as a whole. Patients can expect faster access to critical medications through a more efficient PA process, while providers will enjoy reduced administrative burdens, enabling them to focus on delivering quality care. Overall, the healthcare system stands to benefit from improved efficiency and reduced delays and costs associated with manual prior authorizations.

DrFirst's extensive network, boasting over 270 electronic health record (EHR) systems, 500,000 healthcare providers, and nearly 100 million patients, provides the perfect platform for the widespread adoption of Myndshft's technology. This integration ensures rapid scalability and accessibility across the entire US healthcare market, further solidifying DrFirst's position as a leader in healthcare technology solutions.

Click here to read the original news story.